James increased the price target for DoorDash Inc. (NASDAQ:DASH) to $215 from the previous $170, while maintaining an Outperform rating on the shares. The company, now valued at over $80 billion, has ...
James increased the price target for INmune Bio Inc. (NASDAQ: NASDAQ:INMB) shares to $23 from the previous $18, while maintaining an Outperform rating. According to InvestingPro data, the stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results